about
COPD immunopathologyPulmonary-intestinal cross-talk in mucosal inflammatory diseaseGenome-wide study of percent emphysema on computed tomography in the general population. The Multi-Ethnic Study of Atherosclerosis Lung/SNP Health Association Resource Study.Cytokine inhibition in the treatment of COPD.Prediction of the rate of decline in FEV(1) in smokers using quantitative Computed Tomography.Risk of herpes zoster among patients with chronic obstructive pulmonary disease: a population-based study.Opportunities and challenges in the genetics of COPD 2010: an International COPD Genetics Conference report.Incidence and cost of pneumonia in older adults with COPD in the United StatesActivation of the TLR4 signaling pathway and abnormal cholesterol efflux lead to emphysema in ApoE-deficient mice.Mucolytic Effectiveness of Tyloxapol in Chronic Obstructive Pulmonary Disease - A Double-Blind, Randomized Controlled Trial.Central arterial stiffness is increased among subjects with severe and very severe COPD: report from a population-based cohort study.The Presence of Chronic Mucus Hypersecretion across Adult Life in Relation to Chronic Obstructive Pulmonary Disease DevelopmentImaging in chronic obstructive pulmonary disease.Heme oxygenase-1 prevents airway mucus hypersecretion induced by cigarette smoke in rodents and humans.Pulmonary epithelium, cigarette smoke, and chronic obstructive pulmonary disease.MUC5B is the major mucin in the gel phase of sputum in chronic obstructive pulmonary disease.Current asthma contributes as much as smoking to chronic bronchitis in middle age: a prospective population-based study.Absence of association between SERPINE2 genetic polymorphisms and chronic obstructive pulmonary disease in Han Chinese: a case-control cohort study.Extracellular ATP is involved in dsRNA-induced MUC5AC production via P2Y2R in human airway epithelium.Clinical application of expectorant therapy in chronic inflammatory airway diseases (Review).Acrolein - a pulmonary hazard.The independent and combined effects of lifetime smoke exposures and asthma as they relate to COPD.Omalizumab (anti-IgE) therapy in the asthma-COPD overlap syndrome (ACOS) and its effects on circulating cytokine levels.Positive feedback of the amphiregulin-EGFR-ERK pathway mediates PM2.5 from wood smoke-induced MUC5AC expression in epithelial cells.Matrix metalloproteinase-14 mediates a phenotypic shift in the airways to increase mucin production.Can early diagnosis and effective management combat the irresistible rise of COPD?Acrolein-activated matrix metalloproteinase 9 contributes to persistent mucin production.Nitric oxide donors augment interleukin-1β-induced vascular endothelial growth factor in airway smooth muscle cells.Incidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegm.Risk factors for chronic mucus hypersecretion in individuals with and without COPD: influence of smoking and job exposure on CMHChronic Cough and Phlegm in Young Adults
P2860
Q26749575-293416EA-6BB7-4A66-BCFB-5052167CEBF4Q27693862-A4110DFB-A1A2-4DA6-B815-048F6C6BDF7CQ30408059-4B7C70DD-A9C6-4CAA-9EF6-9BE634DF5F1FQ33568552-5582FF12-CE2B-466B-B87B-D2D93090F190Q34560231-C48DF295-5A45-4F4B-ADAF-5EAC8A68B83FQ34693477-BACB6B15-0B6E-4835-9EE0-4DE1082FDFA5Q34854354-35CC7154-5145-4639-810E-005F128F8E2EQ35018421-0F49703A-451A-4B44-9748-429AF2547614Q36045565-3CA966E7-296F-444D-846E-A345F9CDA3B3Q36053855-1A067923-F1FD-49B9-AD6A-9137512A888CQ36239420-1207E6EC-1DA4-4C8B-8C41-C02DF1044F75Q36778643-3C6855F6-3704-4208-910C-67F088457971Q36832380-A482C698-349D-45F4-AB34-9B1DFBA70E67Q36891496-C91B3BE2-C80E-4EA3-9DBC-1A437BC05AADQ37082562-95E30264-CCA5-4551-B64B-17226072B345Q37098496-28AF2DE7-EAEF-4569-85B0-AF5DE236C5B9Q37194155-1589EC45-300D-4B7A-84C6-515C21566F7AQ37285786-CAFA36B3-4651-46C5-89C8-29FBC41DD7ECQ37291605-95413B0F-1B38-4232-91E1-61DDA657A443Q37652125-9892CADD-70C5-4F15-97F5-91DFA500AC85Q37945138-C6490D0C-87E8-45CE-BDBC-2550E74B5948Q38212257-C9C54F1F-875E-4A6C-8E87-43B2C0626CBCQ40696358-BB4DC44F-600C-4559-8105-1B3815169150Q41325338-6D4CF819-AB23-4FB3-9621-627EF4E9D2ADQ41830515-F093CCFE-894B-4A1C-B3BC-888EA57655F2Q42775942-37ECD715-BC32-4E15-9E98-BEE24389566FQ43087484-66A65337-7E8F-4690-8E2C-94F24FD39BD0Q45349351-11F206DB-8276-4BAE-9216-F192F5B93D25Q53249129-7A9116C5-0931-4E3E-87F7-6CA74FAFAFFFQ57273471-AD885C5B-19E6-477F-9656-9D529E3A4B32Q57955920-236F44AE-5462-415A-A39B-9D29FB1FD66C
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Convergence of the epidemiology and pathology of COPD
@ast
Convergence of the epidemiology and pathology of COPD
@en
type
label
Convergence of the epidemiology and pathology of COPD
@ast
Convergence of the epidemiology and pathology of COPD
@en
prefLabel
Convergence of the epidemiology and pathology of COPD
@ast
Convergence of the epidemiology and pathology of COPD
@en
P2860
P356
P1433
P1476
Convergence of the epidemiology and pathology of COPD
@en
P2093
P2860
P356
10.1136/THX.2005.046227
P407
P577
2005-10-14T00:00:00Z